Alphatec (NASDAQ:ATEC) was downgraded by analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a report released on Friday.
Other equities research analysts also recently issued reports about the stock. Lake Street Capital assumed coverage on shares of Alphatec in a research note on Monday, October 16th. They set a “buy” rating and a $7.00 price objective for the company. HC Wainwright assumed coverage on shares of Alphatec in a report on Monday, August 14th. They set a “buy” rating and a $4.00 target price for the company.
Alphatec (ATEC) traded up $0.03 during trading hours on Friday, hitting $2.65. 78,409 shares of the stock traded hands, compared to its average volume of 87,236. Alphatec has a 1-year low of $1.58 and a 1-year high of $5.80. The company has a debt-to-equity ratio of -1.11, a current ratio of 2.11 and a quick ratio of 1.08.
TRADEMARK VIOLATION WARNING: This piece was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/12/03/alphatec-atec-downgraded-by-valuengine-to-strong-sell.html.
Alphatec Company Profile
Alphatec Holdings, Inc is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Alphatec Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.